The Global Influenza Vaccination Market is expected to grow at an approximate CAGR of 8.2% during the forecast period. America dominates the Global Influenza Vaccination Market Increasing prevalence of the influenza and high per capita healthcare expenditure are the major driver for the American influenza vaccination market. Moreover, the presence of developed economies like the U.S. and Canada and growing geriatric population within the regional boundaries of the Americas fuels the market growth. Europe holds the second market for influenza vaccination owing to the availability of funds for research and huge patient population. Moreover, global players like F. Hoffmann-La Roche Ltd and Novartis AG are present within the region which fuels the market growth. Asia Pacific is the fastest growing region for the market. Presence of developing economies like India and China and favourable government policies along with the growing geriatric population boosts the regional market growth. The Middle East & Africa has the least share in the global influenza vaccination market. Presence of the poor economies in the African region restrains the market growth during the forecast period. Majority of the market of the Middle & Africa region is held by the Middle East region.
Get Premium Sample Copy Free @ https://www.marketresearchfuture.com/sample_request/1621 .
nfluenza (flu) is a contagious respiratory disease that is caused by influenza viruses. Influenza viruses infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. Influenza usually comes on suddenly and may include symptoms such as fever, headache, malaise, cough, sore throat, nasal congestion and body aches. Yearly influenza vaccine can prevent lot of illness and death caused by influenza virus. Influenza vaccine can be given to most individuals 6 months of age and older to protect against influenza.
Segments:
Global Influenza vaccination market has been segmented on the basis of Influenza type which comprises of seasonal, pandemic and zoonotic. On the basis of manufacturing technology, market is segmented into egg based technology; cell culture based technology, recombinant technology. On the basis of end user, market is segmented into hospital, ambulatory, research laboratory and others.
Key Players for Influenza Vaccination Market:
Some of the key players in this market are: Abbott Laboratories, Astrazeneca PLC, Biocryst Pharmaceuticals, Inc., CSL Limited, Daiichi Sankyo Co., Ltd., Glaxosmithkline PLC, Hualan Biological Engineering Inc., Instituto Butantan, Japan Vaccine Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Nanotherapeutics Inc., Protein Sciences Corporation, Roche Holding AG, Sanofi SA, Serum Institute of India Pvt Ltd, Shanghai Institute of Biological Products Co., Ltd., Shionogi & Co., Ltd., Sinovac Biotech Ltd. and others.
Influenza Vaccination Market Major Table of Contents:
1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
TOC Continued….
Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/1621 .
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com .
Your information will never be shared with any third party.